MediciNova, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
MNOV Nasdaq 8731 http://www.medicinova.com 7.47 +0.00

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for MediciNova, Inc.

Options on MediciNova Common Stock Listed on CBOE - Sep 25th, 2016 11:19 pm
Options on MediciNova Common Stock Listed on CBOE - Sep 25th, 2016 11:00 pm
MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Sep 16th, 2016 9:17 pm
MEDICINOVA INC Financials - Jul 30th, 2016 5:04 pm
MNOV: Interim Analysis For Phase 2b Trial of MN-166 in Progressive MS in 4Q16 - Jul 29th, 2016 4:00 pm
MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure - Jul 27th, 2016 10:12 am
MEDICINOVA INC Files SEC form 10-Q, Quarterly Report - Jul 26th, 2016 9:18 pm
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Fibrosis - Jul 24th, 2016 11:28 pm
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Fibrosis - Jul 24th, 2016 11:00 pm
MediciNova Announces Initiation of Interim Efficacy Analysis in Phase 2b Trial of MN-166 (ibudilast) in Progressive MS - Jul 13th, 2016 10:53 am
MediciNova Announces Initiation of Interim Efficacy Analysis in Phase 2b Trial of MN-166 (ibudilast) in Progressive MS - Jul 13th, 2016 10:30 am
MediciNova Announces Results from Clinical Trial of MN-166 (ibudilast) in Alcohol Dependence Presented at the 39th Annual Scientific Meeting of the Research Society on Alcoholism in New Orleans, Louisiana - Jun 29th, 2016 11:31 pm
MediciNova Announces Results from Clinical Trial of MN-166 (ibudilast) in Alcohol Dependence Presented at the 39th Annual Scientific Meeting of the Research Society on Alcoholism in New Orleans, Louisiana - Jun 29th, 2016 11:00 pm
MediciNova Added to Russell 3000® Index and Russell Global Index - Jun 26th, 2016 11:10 pm
MEDICINOVA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - Jun 13th, 2016 10:08 am
MediciNova, Inc. :MNOV-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 - Jun 6th, 2016 6:27 pm
MediciNova Announces Additional Results from the Completed Trial of MN-166 (ibudilast) in Alcohol Dependence to be Presented at the 39th Annual Scientific Meeting of the Research Society on Alcoholism in New Orleans, Louisiana - May 25th, 2016 11:16 pm
MNOV: Positive Trends Seen in Preliminary Data Presented on MN-166 in ALS - Apr 29th, 2016 8:25 pm
MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure - Apr 28th, 2016 10:21 am
MEDICINOVA INC Files SEC form 10-Q, Quarterly Report - Apr 27th, 2016 8:55 pm